Literature DB >> 10809977

Evidence for Borrelia burgdorferi in morphea and lichen sclerosus.

S Ozkan1, N Atabey, E Fetil, V Erkizan, A T Günes.   

Abstract

BACKGROUND: Borrelia burgdorferi (Bb) infection has been implicated in the development of morphea and lichen sclerosus; however, conflicting results have been reported with different investigational methods from different regions. We looked for evidence of Bb in patients with morphea and lichen sclerosus by polymerase chain reaction (PCR) analysis of of skin biopsy samples.
METHODS: Formalin-fixed, paraffin-embedded skin biopsy samples from 10 patients with morphea and 12 patients with lichen sclerosus were investigated by PCR analysis for the presence of Bb.
RESULTS: The presence of Bb DNA was demonstrated in three of 10 patients with morphea and six of 12 patients with lichen sclerosus by nested PCR.
CONCLUSIONS: The data obtained in this study suggest that Bb may play a role in the etiopathogenesis of both morphea and lichen sclerosus at least in the western parts of Turkey.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10809977     DOI: 10.1046/j.1365-4362.2000.00912.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  13 in total

1.  Borrelia burgdorferi Infections in the United States.

Authors:  Warren R Heymann; Dana L Ellis
Journal:  J Clin Aesthet Dermatol       Date:  2012-08

2.  Evaluation of skin thickness lesions in patients with Lyme disease measured by modified Rodnan total skin score.

Authors:  A Moniuszko; E Gińdzieńska-Sieśkiewicz; S A Pancewicz; P Czupryna; J Zajkowska; S Sierakowski
Journal:  Rheumatol Int       Date:  2011-09-30       Impact factor: 2.631

Review 3.  Morphoea and Borrelia burgdorferi: results from the Scottish Highlands in the context of the world literature.

Authors:  J R Goodlad; M M Davidson; P Gordon; R Billington; D O Ho-Yen
Journal:  Mol Pathol       Date:  2002-12

Review 4.  Systemic and localized scleroderma in children: current and future treatment options.

Authors:  Margalit E Rosenkranz; Lucila M A Agle; Petros Efthimiou; Thomas J A Lehman
Journal:  Paediatr Drugs       Date:  2006       Impact factor: 3.022

Review 5.  Development of minimum standards of care for juvenile localized scleroderma.

Authors:  Tamás Constantin; Ivan Foeldvari; Clare E Pain; Annamária Pálinkás; Peter Höger; Monika Moll; Dana Nemkova; Lisa Weibel; Melinda Laczkovszki; Philip Clements; Kathryn S Torok
Journal:  Eur J Pediatr       Date:  2018-05-04       Impact factor: 3.183

6.  Pansclerotic morphea in childhood: a case report.

Authors:  T Doede; U Wollina; W Hindermann; F Schier; M Bondartschuk
Journal:  Pediatr Surg Int       Date:  2003-06-21       Impact factor: 1.827

7.  Frequency of Borrelia in Morphea Lesion by Polymerase Chain Reaction in Northeast of Iran.

Authors:  Mohhamad Javad Yazdanpanah; Norieh Sharifi; Alireza Khooei; Mahnaz Banihashemi; Mohammad Khaje-Daluee; Azadeh Shamsi; Kiarash Ghazvini
Journal:  Jundishapur J Microbiol       Date:  2015-08-27       Impact factor: 0.747

8.  Lyme borreliosis and skin.

Authors:  Biju Vasudevan; Manas Chatterjee
Journal:  Indian J Dermatol       Date:  2013-05       Impact factor: 1.494

Review 9.  Diagnosis and treatment of lichen sclerosus: an update.

Authors:  Susanna K Fistarol; Peter H Itin
Journal:  Am J Clin Dermatol       Date:  2013-02       Impact factor: 7.403

10.  Infections are not increased in scleroderma compared to non-inflammatory musculoskeletal disorders prior to disease onset.

Authors:  Janet E Pope; Jodi L Goodwin; Janine M Ouimet; Adriana Krizova; Matthew Laskin
Journal:  Open Rheumatol J       Date:  2007-11-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.